CRS patients with increased serum total IgE (≥ 100 IU/mL) did not show differences in any of the clinical or patient‐reported outcome parameters compared to those with serum total IgE < 100 IU/mL (Figure 3). This evidence concerns the gene IGHE and congenital rubella syndrome.